Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 9651 - 9675 of 9812 in total

Ortataxel

Ortataxel has been used in trials studying the treatment of Lymphoma, Lung Cancer, Glioblastoma, and Kidney Cancer.
Investigational

Mirodenafil

Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.
Investigational

Milataxel

Milataxel has been used in trials studying the treatment of Mesothelioma.
Investigational

Sabarubicin

Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational

Lecozotan

Lecozotan has been used in trials studying the treatment of Alzheimer Disease.
Investigational

Indoximod

Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.
Investigational

Acoziborole

SCYX-7158 has been used in trials studying the treatment of Trypanosomiasis, Parasitic Diseases, Protozoan Infections, and Trypanosomiasis, African.
Investigational

Neltenexine

Neltenexine is an elastase inhibitor. It may be useful for preventing pulmonary emphysema.
Experimental

Furazidin

Experimental

Nifurtoinol

Experimental

Flunisolide acetate

Experimental

AZD-3759

AZD-3759 is under investigation in clinical trial NCT03360929 (Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759).
Investigational

[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid

Experimental

3-Iodo-Tyrosine

Experimental

Adenosine Phosphonoacetic Acid

Experimental

N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate

Experimental

5-fluorotryptophan

5-fluorotryptophan can be used as substrate analogue to study enzyme mechanisms by NMR spectroscopy.
Experimental

N-Pyridoxyl-Threonine-5-Monophosphate

Experimental

4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

OSI-930

OSI-930 is an orally active inhibitor of two clinically validated targets: c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2). OSI-930 is designed to target both cancer cell proliferation and blood vessel growth (angiogenesis) in selected tumors. In preclinical studies, OSI-930 shows broad efficacy in tumor models representative of small...
Investigational

Quarfloxin

Investigational

N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE

Experimental

5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE

Experimental

R-95845

R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental

5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE

Experimental
Displaying drugs 9651 - 9675 of 9812 in total